Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other Psychoactive Substance Use, Unspecified with Psychoactive Substance-Induced Mood Disorder
- ICD-10 Code: F19.94
Summary
This condition involves the use of a psychoactive substance not classified under more specific categories (e.g., alcohol, cannabis, opioids) where the substance is unidentified, and a mood disorder is present as a direct result of the substance use. It is classified as "unspecified" when the exact agent is unknown or not documented, and "with psychoactive substance-induced mood disorder" indicates the mood disturbance is attributable to the substance’s effects.
Causes
The condition may result from experimentation, recreational use, or habitual consumption of various psychoactive substances. These substances can alter perception, mood, cognition, or behavior, though the specific agent is not specified. The mood disorder arises from the direct physiological or psychological effects of the substance on the central nervous system.
Risk Factors
- Peer pressure or cultural acceptance of substance use.
- Stressful life circumstances or co-occurring mental health conditions (e.g., anxiety, depression).
- Availability of and access to psychoactive substances.
Symptoms
Symptoms vary based on the substance but may include altered perception, mood swings, impaired judgment, or changes in behavior. The mood disorder may present as depressive or manic symptoms, such as persistent sadness, irritability, or elevated mood, directly linked to the substance use. The exact presentation depends on the unidentified psychoactive agent.
Diagnosis
Diagnosis typically involves a clinical assessment, including patient history and behavioral observations. Lab tests may be used if the substance identity is unknown, though no specific tests are standard. The mood disorder must be determined to be directly caused by the substance use, not an independent condition.
Treatment Options
- Counseling and Behavioral Therapies: Aim to modify substance use behaviors and address mood symptoms.
- Medication Management: May include mood stabilizers or antidepressants, if clinically appropriate, to manage the induced mood disorder.
- Support Groups: Provide a community for ongoing recovery and coping strategies.
Prognosis and Follow-Up
Prognosis depends on the severity of substance use and the mood disorder, as well as adherence to treatment. Regular follow-up is important to monitor for relapse, mood stability, and any emerging complications. Long-term recovery often requires sustained behavioral and pharmacological interventions.
Complications
- Worsening of mood symptoms, including suicidal ideation.
- Increased risk of substance dependence or other substance-related disorders.
- Impaired social, occupational, or educational functioning.
Lifestyle & Prevention
- Avoiding known psychoactive substances and environments where they are used.
- Engaging in stress-reduction techniques, such as exercise or mindfulness.
- Building a support network of family, friends, or peers in recovery.
When to Seek Professional Help
Seek immediate care if experiencing severe mood changes, thoughts of self-harm, or inability to manage substance use. Ongoing professional support is recommended for persistent mood symptoms or recurrent substance use.
Tips for Medical Coders
Document the presence of the mood disorder and its direct link to the unspecified psychoactive substance use. Ensure the substance is not identified and no other complications (e.g., intoxication, withdrawal) are present. Code F19.94 when the mood disorder is the primary substance-induced condition and the substance remains unspecified.
Medical Policies and Guidelines
Related policies from health plans
F19.94 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.